a statistical approach
December 2, 2025: Australian Government Issues Warning About Ozempic and Reports of Suicidality, Self-Harm The Therapeutic Goods Administration in Australia (a government agency similar to the FDA in the U.S.) warns that a concerning number of patients who take Ozempic and other GLP-1s reported suicidal ideation and self-harm
The first is combination protocols pairing complementary mechanisms (the CagriSema approach of cagrilintide plus semaglutide)
Some researchers have pointed out that the common digestive adverse reactions of the drug (diarrhea, vomiting, loss of appetite) may be contributing to their supposed weight loss success and are not ideal ways to support metabolic health at its foundation
, 432 F.3d 1368, 137879 (Fed
J., Marsillo, A., & El Idrissi, A